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Background
ALS is a fatal, rapidly progressive neurodegenerative dis-
order affecting motor neurons in the CNS; this results in
muscle weakness which progresses to paralysis and death
from respiratory failure. There is currently no effective
cure as its pathophysiology is poorly understood; how-
ever, aggregates comprising misfolded proteins are
known to be characteristic of the disease. These protein
aggregations could elicit ER stress and subsequently the
unfolded protein response (UPR). Initially, this response
is cytoprotective as it inhibits protein synthesis thereby
preventing further protein accumulation until the stress
resolves, however if prolonged it can stimulate apoptosis.
This study attempts to clarify the role of ER stress and
the UPR in ALS.
Methods
Immunofluorescence was performed on SOD1 mice
spinal cord sections at two time points, PND90 and
endstage, which were compared to wild type controls.
Antibodies were used against ER stress markers ATF6,
CHOP, PERK, IRE1 and p-eif2a with SMI32, NeuN or
GFAP used as co-stains for distinguishing the cell type
and signal co-localization. Immunofluorescence was
then optimized to eliminate autofluorescence and anti-
gen masking in the FFPE human tissue. Human spinal
cord samples from 5 patients with ALS and 5 controls
were then analysed by Nissl staining to assess the histol-
ogy and with the ATF6 antibody to assess levels of ER
stress.
Results
P-eif2a, nuclear ATF6, CHOP and PERK levels were ele-
vated in the endstage transgenic mice compared to the
PND90 and wild type samples. The p-eif2a co-localised
with the NeuN neuron stain. Further results from the
human tissue immunofluorescence are pending.
Conclusions
ER stress was shown to be increased in the SOD1 mouse
model compared to controls; these mice are a model for
ALS as 20% familial ALS cases carry the same mutation.
Co-localisation of the NeuN with the p-eif2a implies a
neuronal location of the stress. This indicates the UPR’s
involvement in the pathophysiology of ALS and suggests it
may be a delayed response or a consequence of the disease
as markers were exceedingly elevated in the endstage com-
pared to the day 90 mouse spinal cords. The ER stress
pathway could potentially be a novel therapeutic target in
ALS with many emerging drugs modifying the UPR and if
identified to be raised in other more accessible tissue in
ALS patients it could potentially be used as a biomarker
for early disease diagnosis.
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